| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Surgery, University of Michigan Medical School, Ann Arbor, Michigan 48109; and 2 Merck Research Laboratories, Rahway, New Jersey 07065
The melanocortin system consists of melanocortin peptides derived from the proopiomelanocortin gene, five melanocortin receptors, two endogenous antagonists, and two ancillary proteins. This review provides an abbreviated account of the basic biochemistry, pharmacology, and physiology of the melanocortin system and highlights progress made in four areas. In particular, recent pharmacological and genetic studies have affirmed the role of melanocortins in pigmentation, inflammation, energy homeostasis, and sexual function. Development of selective agonists and antagonists is expected to further facilitate the investigation of these complex physiological functions and provide an experimental basis for new pharmacotherapies.
inflammation; obesity; pigmentation; sexual function; receptor
This article has been cited by other articles:
|
|
 |
|
  G. Leoni, H. B. Patel, A. L. F. Sampaio, F. N. E. Gavins, J. F. Murray, P. Grieco, S. J. Getting, and M. Perretti Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion FASEB J, December 1, 2008; 22(12): 4228 - 4238. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K A. H Iwen, O. Senyaman, A. Schwartz, M. Drenckhan, B. Meier, D. Hadaschik, and J. Klein Melanocortin crosstalk with adipose functions: ACTH directly induces insulin resistance, promotes a pro-inflammatory adipokine profile and stimulates UCP-1 in adipocytes J. Endocrinol., March 1, 2008; 196(3): 465 - 472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. J. Nadeau, F. Minvielle, S. Ito, M. Inoue-Murayama, D. Gourichon, S. A. Follett, T. Burke, and N. I. Mundy Characterization of Japanese Quail yellow as a Genomic Deletion Upstream of the Avian Homolog of the Mammalian ASIP (agouti) Gene Genetics, February 1, 2008; 178(2): 777 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Catania The melanocortin system in leukocyte biology J. Leukoc. Biol., February 1, 2007; 81(2): 383 - 392. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. Williams and K. B. Donnelly Gastric Mucosal Damage Following Repeat Administration of Melanocortin Subtype-4 Receptor Ligands to Fischer 344 Rats Toxicol Pathol, October 1, 2006; 34(6): 738 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nakayama and T. Ishida Alu-mediated 100-kb deletion in the primate genome: The loss of the agouti signaling protein gene in the lesser apes. Genome Res., April 1, 2006; 16(4): 485 - 490. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-P. Ni, A. Bhargava, D. Pearce, and M. H. Humphreys Modulation by dietary sodium intake of melanocortin 3 receptor mRNA and protein abundance in the rat kidney Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R560 - R567. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cooper, S. J. Robinson, C. Pickard, C. L. Jackson, P. S. Friedmann, and E. Healy {alpha}-Melanocyte-Stimulating Hormone Suppresses Antigen-Induced Lymphocyte Proliferation in Humans Independently of Melanocortin 1 Receptor Gene Status J. Immunol., October 1, 2005; 175(7): 4806 - 4813. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Feng, S. F. Young, G. Aguilera, E. Puricelli, D. C. Adler-Wailes, N. G. Sebring, and J. A. Yanovski Co-occurrence of Two Partially Inactivating Polymorphisms of MC3R Is Associated With Pediatric-Onset Obesity Diabetes, September 1, 2005; 54(9): 2663 - 2667. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Metz, E. J. W. Geven, E. H. van den Burg, and G. Flik ACTH, {alpha}-MSH, and control of cortisol release: cloning, sequencing, and functional expression of the melanocortin-2 and melanocortin-5 receptor in Cyprinus carpio Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2005; 289(3): R814 - R826. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Chen, S. M. Williams, K. L. Grove, and M. S. Smith Melanocortin 4 Receptor-Mediated Hyperphagia and Activation of Neuropeptide Y Expression in the Dorsomedial Hypothalamus during Lactation J. Neurosci., June 2, 2004; 24(22): 5091 - 5100. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Catania, S. Gatti, G. Colombo, and J. M. Lipton Targeting Melanocortin Receptors as a Novel Strategy to Control Inflammation Pharmacol. Rev., March 1, 2004; 56(1): 1 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Humphreys {gamma}-MSH, sodium metabolism, and salt-sensitive hypertension Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2004; 286(3): R417 - R430. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Klovins, T. Haitina, D. Fridmanis, Z. Kilianova, I. Kapa, R. Fredriksson, N. Gallo-Payet, and H. B. Schioth The Melanocortin System in Fugu: Determination of POMC/AGRP/MCR Gene Repertoire and Synteny, As Well As Pharmacology and Anatomical Distribution of the MCRs Mol. Biol. Evol., March 1, 2004; 21(3): 563 - 579. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
